U.S. Will Increase Production of the Ebola Drug ZMapp, but May Not Meet Demand

Supplies of ZMapp, which is seen as the most promising experimental treatment for Ebola, are expected to be limited to hundreds or thousands of treatment courses by early 2015.

via NYT > Business Day http://ift.tt/1psZd4N

via WordPress http://ift.tt/1oDSRQ7